Qualtex Corporation

What Qualtex Corporation does

Qualtex Corporation operates as the testing and biomanufacturing arm of BioBridge Global, a nonprofit organization headquartered in San Antonio, Texas that has been operating since 1973. Qualtex provides infectious disease testing, biological product testing, and contract biomanufacturing services to a customer base that includes more than 100 hospitals across South Texas along with national and international biomedical clients. Core laboratory operations run on the ACCELERATOR a3600 automation platform and operate under cGMP conditions with EU-graded modular cleanrooms, supporting throughput of more than 7 million tests per year across the broader BioBridge ecosystem.

The broader enterprise includes QualTex Laboratories (testing), GenCure (biomanufacturing and cord blood banking), and the South Texas Blood & Tissue Center, sharing a donor network of more than 35,000 recallable donors accumulated over 50+ years of operations. The Mobile Leukapheresis Center, described as the world's first of its kind, enables decentralized cell collection supporting CAR T-cell therapy manufacturing partners including Kite Pharma (Gilead). The 2024 launch of BBG Advanced Therapies formalized an enterprise pivot into cell and gene therapy biomanufacturing, evidenced by partnerships with Kite and VERIGRAFT. Revenue is generated through a mix of per-test lab service fees, hospital supply contracts for blood and tissue products, and enterprise biomanufacturing agreements with biotech and pharmaceutical clients.

Name

Qualtex Corporation

Legal name

BioBridge Global

Website

https://biobridgeglobal.org

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

51–100 employees

Short description

Qualtex Corporation is the testing and biomanufacturing subsidiary of BioBridge Global, providing infectious disease testing, biological product testing, and cell/gene therapy manufacturing services to South Texas hospitals and national biotech clients.

Ownership category

akta.pro rank

Product category

Blood & Plasma Testing Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industries

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

• Blood testing services
• Plasma screening
• Donor screening
• Microbiology testing
• Advanced therapies testing

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Blood Products Distribution: Supply of blood components including red blood cells, platelets, plasma, and cryoprecipitate to hospitals; revenue from blood banking services to healthcare providers
2. Testing Services: Screening millions of blood and plasma donations for national and international biomedical customers; includes donor screening, microbiology testing, and advanced therapies testing
3. Biomanufacturing Services: cGMP biomanufacturing for advanced therapies including process development, cell isolation, and commercial production; revenue from pharmaceutical and biotech partners
4. Cord Blood Banking: Collection, processing, storage and distribution of cord blood units for transplant and research
5. Tissue Services: Recovery, testing, storage and distribution of perinatal tissue and other tissue types for transplantation and research

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

QualTex Laboratories operates as one of the largest independent, nonprofit testing laboratories in the United States for blood and plasma products. Headquartered in San Antonio, Texas with an additional facility in Norcross, Georgia, QualTex screens millions of blood and plasma donations annually for national and international biomedical customers using the ACCELERATOR a3600 automated laboratory system. The four core testing services are Donor Screening (infectious disease detection via ELISA and PCR), Microbiology Testing, Advanced Therapies Testing (for cell and gene therapy products), and an Immunohematology Reference Laboratory (IRL) for specialized blood typing and antibody identification.

Product overview

QualTex Laboratories is a subsidiary of BioBridge Global and operates as one of the largest independent, nonprofit testing laboratories in the United States for blood and plasma products. Headquartered in San Antonio, Texas with an additional facility in Atlanta, Georgia, QualTex screens millions of blood and plasma donations annually for national and international biomedical customers. The company operates the ACCELERATOR a3600 Laboratory Automation System at both facilities to support high-throughput testing operations. QualTex's portfolio is organized around four core testing services: Donor Screening (infectious disease detection via ELISA and PCR), Microbiology Testing, Advanced Therapies Testing (for cell and gene therapy products), and an Immunohematology Reference Laboratory (IRL) for specialized blood typing and antibody work.

Differentiator

Problem solved

Functional benefit

Brands

• Community Labs: COVID-19 testing laboratory launched to provide fast, accurate and inexpensive tests to schools and businesses across South Texas.
• GenCure
• Mobile Leukapheresis Center

Products and services

• Donor Screening

Quantifiable outcome

• 100,000+ blood donations collected annually
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Kite (Gilead Company)coreStrategic or Co-development Partner · 7 July 2026BBG Advanced Therapies collaboration with Kite to deploy Mobile Leukapheresis Center to bring CAR T-cell therapies closer to patients. The collaboration expands access to cell collection services for patients preparing for cell therapies.
• VERIGRAFTcoreStrategic or Co-development Partner · 24 June 2026BBG Advanced Therapies collaboration with VERIGRAFT to support U.S. development readiness for new vein therapy. Partnership supports clinical and commercial programs for regenerative medicine.
• National Institutes of Health All of Us Research ProgramcoreStrategic or Co-development Partner · 1 January 2022Partnership to recruit and engage participants in one of the nation's largest and most diverse health information databases
• University Health SystemcoreStrategic or Co-development PartnerCollaboration with University Health System at the Center for Life for tissue recovery services and transplant support
• Texas Organ Sharing AlliancecoreStrategic or Co-development PartnerPartnership for organ and tissue donation coordination and support services
• San Antonio Eye BankminorStrategic or Co-development PartnerCollaboration for eye donation and tissue recovery services
• Donate Life TexasminorStrategic or Co-development PartnerPartnership to promote organ, tissue, and eye donation within the community
• BioMedSAminorStrategic or Co-development PartnerSponsor of member-driven hub promoting and supporting life sciences industry in San Antonio
• The Health CellminorStrategic or Co-development PartnerCollaboration with biotechnology, medical, military and academic leadership to promote professional development and collaboration in local healthcare community
• RegenMed SAminorStrategic or Co-development PartnerParticipation in local organization formed to promote stem cell research, tissue engineering, regenerative medicine and biotechnology

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Lonza: Global cell-and-gene-therapy CDMO with large-scale cGMP manufacturing capacity for autologous and allogeneic therapies. Comparable to BBG Advanced Therapies on cGMP biomanufacturing, but operating at much greater global scale and capital intensity.
• Bio-Rad Laboratories: Major supplier of blood-typing, immunoassay and quality-control reagents used in donor screening and immunohematology reference labs. Comparable to QualTex's IRL and donor-screening workflows as a supplier-incumbent with overlapping customers.
• American Red Cross Blood Services: Largest U.S. blood collector, supplying roughly 40% of the nation's blood supply and operating centralized testing laboratories. Comparable to BioBridge Global/QualTex on the integrated donor-to-hospital model and national testing footprint.
• Hologic: Global diagnostics company whose Panther system is widely deployed for nucleic-acid blood-screening in donor centers. Indirect peer/incumbent whose instruments and reagents underpin much of the high-throughput testing QualTex performs.
• Immucor: Specialist in transfusion and transplantation diagnostics, including automated immunohematology instruments and reagents used by IRLs. Comparable to QualTex's Immunohematology Reference Laboratory on products, customers and accreditation footprint.
• New York Blood Center: Large nonprofit blood collector and one of the largest independent blood centers in the world, with extensive research, cellular therapy and cord blood banking operations. Comparable to BioBridge Global across collection, testing, advanced therapies and cord blood.
• Vitalant: One of the largest nonprofit blood collectors in the U.S., operating a national network of donor centers and in-house testing/biomanufacturing. Comparable to BioBridge Global as a vertically integrated blood and cellular therapy operator, but at significantly larger national scale.

Direct peers

• Creative Testing Solutions: Largest independent donor-screening laboratory in the United States, performing infectious-disease and blood/plasma testing for major blood centers. Closest direct peer to QualTex Laboratories in donor screening, microbiology and high-throughput automation.

Emerging players

• Cerus: Developer of INTERCEPT pathogen-reduction technology for blood components and plasma, increasingly adopted by blood centers. Comparable to QualTex as an adjacent technology provider serving the same hospital and blood-center customers.

Regional players

• Carter BloodCare: Texas-based regional blood center serving North, Central and East Texas hospitals, with collection, testing and reference lab services. Direct Texas-market overlap with South Texas Blood & Tissue, providing an apples-to-apples regional peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/SouthTexasBlood
• YouTubeyoutube.com/@SouthTexasBlood
• Facebookfacebook.com/SouthTexasBloodandTissue
• LinkedInlinkedin.com/company/qualtex-labs
• Instagraminstagram.com/southtexasblood

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qualtex Corporation